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Summary 
The pathogenic potential of autoimmune T cell responses to nonmyelin autoantigens was investigated 
in the Lewis rat using the astrocyte-derived calcium binding protein $100/3, as a model nonmyelin 
autoantigen. The Lewis rat mounts a vigorous RT1B 1 (major histocompatibility complex class 
II) restricted autoimmune response to an immunodominant $100/3 epitope (amino acid residues 
76-91). The adoptive transfer of S100/3-specific T cell lines induced a severe inflammatory response 
in the nervous system, but only minimal neurological dysfunction in naive syngeneic recipients. 
The inability of S100j3-specific T cell transfer to induce severe disease was associated with a decreased 
recruitment of ED1 § macrophages into the central nervous system (CNS) in comparison with 
that seen in severe experimental autoimmune encephalomyelitis (EAE) induced by the adoptive 
transfer of myelin basic protein (MBP)-specific T  line cells. Moreover, unlike encephalitogenic 
MBP-specific T  cell lines,  S100/3-specific T  cell lines exhibited no cytotoxic activity in vitro. 
Histopathological analysis also revealed striking differences in the distribution of inflammatory 
lesions in MBP- and S100/3-specific T  cell-mediated disease. In contrast to the MBP paradigm, 
S100/3-specific T  cell transfer induces intense inflammation not only in the spinal cord, but 
throughout the entire CNS and also in the uvea and retina of the eye. In view of the distribution 
of lesions throughout the grey and white matter of the CNS we propose to term this new model 
experimental autoimmune panencephalomyelitis (EAP)  to  differentiate it  from EAE.  These 
experiments demonstrate for the first time that  nonmyelin CNS autoantigens can initiate a 
pathogenic autoimmune T cell response, although the nature of the target autoantigen profoundly 
influences the clinical and histopathological characteristics of the resulting autoimmune disease. 
This is not simply a consequence of the distribution of the autoantigen, as both MBP and $100/3 
are coexpressed in many areas of the CNS, but reflects differences in the capacity of different 
regions of the CNS to process and present specific autoantigens. This new model of T cell-mediated 
autoimmune CNS disease exhibits a number of similarities to multiple sclerosis (MS), such as 
its mild clinical course and the involvement of areas of the brain and eye, which are absent in 
myelin-mediated models of EAE. Nonmyelin autoantigens may therefore play an unexpectedly 
important role in the immunopathogenesis of inflammatory diseases of the CNS. 
T 
wo basic tenets in cellular immunology were radically 
revised during the past decade as a direct consequence 
of studies of experimental autoimmune encephalomyelitis 
(EAE)  1. First,  the concept of "immunoprivilege" with re- 
1 Abbreviations used in this paper: BBB, blood-brain barrier; CNS, central 
nervous system;  EAE, experimental  autoimmune  encephalomyelitis;  EAP, 
experimental  autoimmune  panencephalitis;  MOG, myelin  oligodendrocyte 
glycoprotein; MS, multiple sclerosis; PPD, purified protein derivative. 
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Volume 180  September  1994  817-829 spect to the central nervous system (CNS) was reappraised 
after the demonstration that not only can activated T lympho- 
cytes migrate through the endothelial blood-brain barrier 
(BBB) regardless of their antigen specificity (1, 2); but also 
that the CNS contains numerous cellular elements (astrocytes, 
microglia, cerebral endothelial cells) that can function as APCs 
(3-5). Second, the isolation of encephalitogenic T cell lines 
from both myelin-primed (6) and naive rats (7) demonstrated 
that potentially autoaggressive T  cell clones are not neces- 
sarily silenced by either deletion or anergy, but are normal 
components of the healthy immune repertoire (8,  9). 
However, these results are all derived from studies in which 
EAE is mediated by an autoaggressive T cell response against 
a single myelin antigen, the myelin basic protein (MBP), which 
until very recently appeared to be the predominant, if not 
the only, encephalitogenic protein present in the CNS. Analysis 
of the encephalitogenic, MBP-specific T cell response revealed 
that it exhibited several unusual properties. In at least two 
species,  the Lewis rat  and mice with  the H-2  u haplotype 
(PL/J and B10.PL strains), the primary MBP-specific T cell 
response is directed against single, strongly immunodominant 
epitopes, the identity of which is species and strain depen- 
dent. Furthermore, encephalitogenic T cells specific for these 
immunodominant epitopes use a highly restricted repertoire 
of TCK genes, generally TCR V~8.2 in combination with 
V~2/V~4 elements (10-13).  The potential therapeutic rele- 
vance of these observations was rapidly demonstrated in EAE 
(14-18);  however, the molecular characteristics responsible 
for the encephalitogenicity of the MBP-specific T cell response 
have still to be elucidated. In particular, it has to be demon- 
strated whether EAE mediated by myelin-specific T cells pro- 
vides a general paradigm to study inflammatory responses 
in the CNS,  or is a special case of limited usefulness. 
To approach this problem and identify the structural/func- 
tional characteristics of CNS proteins necessary to induce EAE, 
we elected to study the encephalitogenic potential of non- 
myelin CNS proteins that differ from MBP with respect to 
their site of synthesis and physicochemical  characteristics.  One 
of these proteins was $100/3, a calcium binding protein that 
was first isolated from the CNS.  S100B is a small, highly 
soluble, acidic protein consisting of 91 amino acids (19, 20). 
Like MBP, S100B is a major component of the nervous system, 
accounting for •0.4%  of the total soluble protein in the CNS 
(21), but unlike MBP which is only present in oligodendro- 
cytes and myelin, expression of $100/3 in the CNS is restricted 
to astrocytes. Elsewhere, $100~ is also expressed by Schwann 
cells in the peripheral nervous system and Mtiller cells in the 
retina (22, 23). Astrocytes also secrete a biologically active 
form  of SIOOB and  the  protein  can  be  detected  in  the 
cerebrospinal fluid (24,  25). 
To provide a direct comparison with the encephalitogenic 
MBP-specific T cell response a panel of S100/3-specific T cell 
lines was generated from both bulk,  and limiting dilution 
cultures of lymph node cells obtained from S100B-primed 
animals. These T cell lines were then analyzed in vitro with 
respect to their epitope specificity, phenotype, TCR V0 gene 
usage, cytokine production, and cytotoxicity, and in vivo after 
adoptive transfer into naive syngeneic recipients to determine 
Table  1.  Amino Acid Sequences of the Synthetic Rat SlO0~ 
Peptides Used in This Study 
Designation  Residues  Amino acid sequence 
A4  1-14 
B4  4-18 
C4  10-24 
D4  15-20 
E4  20-34 
F4  25-39 
A5  31-45 
B5  36-50 
C5  41-55 
D5  46-60 
E5  51-65 
F5  56-70 
A6  61-75 
B6  66-80 
C6  71-85 

















Bovine $100~ protein differs from rat S100B at residues 7 (Met/Val), 
62 (Glu/Ser), 78 (Ser/Ala), and 80 (Val/lle). 
their pathogenic potential. S100B-specific, class II MHC-re- 
stricted, CD4 § Thl T  line cells were found to mediate an 
intense inflammatory response throughout the CNS that differs 
dramatically from MBP-mediated EAE with respect to le- 
sion distribution, structure and cellular composition. Addi- 
tionally, S100B-specific T cells induce inflammatory changes 
in both the uvea and retina of the eye, a pathology reported 
to occur in a subgroup of patients with multiple sclerosis 
(MS)  (26). 
These observations demonstrate that MBP and other my- 
elin proteins are not the only CNS autoantigens able to in- 
duce  extensive  autoimmune-mediated  encephalomye- 
litis/panencephalomyelitis in mammals. A potential role for 
autoimmune responses to nonmyelin autoantigens will now 
have to be considered the pathogenesis of inflammatory dis- 
eases of the CNS,  in particular MS. 
Materials and Methods 
Animats and Antigens.  Inbred Lewis rats aged 6-8 wk were ob- 
tained from the animal breeding facilities  of the Max-Planck Insti- 
tute (Martinsried, Germany). Bovine $100/3 protein was obtained 
from Sigma Chemical Co. (St. Louis, MO). Synthetic rat S100B 
peptides were prepared  by Dr. N. Groome (Oxford Brookes Univer- 
sity, Oxford, UK) on a multiple peptide synthesizer (Abimed, Dus- 
seldorf, Germany) using standard Fmoc chemistry (Table 1). Pep- 
tide purity was monitored by amino acid analysis, reverse-phase 
HPLC and, when appropriate, mass spectrometry. 
mAbs and Anti-sera.  The following mAbs were used in this 
study: OX6 (RT1.B, rat I-A), OX17 (RT.1D, rat I-E), and OX18 
(MHC class I), W3/13 (pan T cell/granulocyte); W3/25 (CD4); 
OX8 (CDS); OX39, II.-2 receptor; OX22 (CD45RO).  The suc- 
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stant region of TCR-ce//3 [27]);  R78 (TCR Vo 8.2);  B73  (TCR 
V08.5);  and G101 (TCR Val0) (28) and HIS42 (TCR Vol6). Rat 
macrophages and microglia were differentiated using the mAbs 
TRPM3  (29),  ED1, ED2,  ED3 (30),  and MUC102  (31). Rabbit 
anti-S100~  and  anti-GFAP antisera were purchased  from Sigma 
Chemical Co. W3/13, W3/25, OXS, OX39, and MUC102 were 
purified in our laboratory from the culture supernatants of the ap- 
propriate hybridoma cell lines; ED mAbs, OX22, OX42, and HIS42 
were purchased from Serotec (Oxford, UK) and TR.PM3 from Di- 
anova (Hamburg, Germany). 
Antigen-specific T Cell Lines.  Lewis rats were immunized in the 
hind foot pads with either 50/ig native antigen ($100~  protein, 
guinea pig MBP, or purified protein derivative [PPD]), or 35 #g 
of synthetic peptide, in complete Freund's Adjuvant (CFA) con- 
taining 4 mg/ml Mycobacterium tuberculosis  H37a (Difco Laborato- 
ries,  Inc., Detroit,  MI). 
Two different protocols were used to establish antigen specific 
T cell lines.  10 d after immunization single cell suspensions were 
prepared from the draining lymph nodes. The primed cells were 
either cultured at a concentration of 107 cells/ml to establish  bulk 
T  cell lines  (LS) (6),  or alternatively serially diluted to provide a 
large number of pauciclonal T cell lines (prefixed;  S1 [32]).  In the 
latter case, lymph node cell suspensions were cultured in 96-well 
round-bottom microtiter plates at cell numbers ranging from 2  x 
105 to 100 cells/well. The wells were supplemented with antigen 
and irradiated  (4,000 rad)  syngeneic thymus cells to give a final 
cell number of 2  x  10Vwell. After 3 d,  the media was removed 
and the remaining T cells expanded for a further 7-10 d in media 
supplemented with IL-2. The T cells were then restimulated with 
antigen in the presence of 2  x  l0  s irradiated (4,000 rad) syngeneic 
thymus cells/well.  After visual inspection of the cultures,  those 
positive for growth were expanded in  the presence of IL-2 and 
antigen-specific S1 T  cell lines  selected  as described for the bulk 
culture-derived LS cell lines. The LS and S1 T cell lines were then 
subsequently propagated as described previously (6,  33). 
Proliferation and L ymphokine Assays.  Lymph node cells  (2  x 
10S/well), or 2  x  104 T line cells plus 0.9  x  106 irradiated (4,000 
rad) syngeneic thymocytes were cultured in 0.2 ml medium in 96- 
well round-bottomed microtiter plates in the presence or absence 
of the appropriate antigens.  After 56  h,  1 #Ci/well  [3H]thymi- 
dine was added and the cells were harvested 16 h later.  The mean 
cpm were determined for triplicate cultures using a solid phase gas 
scintillation  counter  (Matrix 96  Direct  Beta Counter;  Packard, 
Frankfurt, Germany). It should be noted that the counts obtained 
by  this  method  are  approximately five  times  lower  than  with 
methods using scintillation  fluid. 
The ability of either syngeneic astrocytes or the mouse L cell 
line,  RT3.3,  which is transfected with functional RTIB  1 to act 
as APCs was determined using irradiated cultures (5,000 tad) seeded 
into flat bottomed 96-well plates at a density of 2  x  104 cells/weU. 
T  line cells (2  x  104/well)  were added to give a total volume of 
0.2 ml media in the presence or absence of antigen. T cell prolifera- 
tion was determined at the end of 3 d culture as described above. 
The cell line RT3.3 was established using the mulcos system (34) 
(a kind gift from Dr. I. Saito, National Institutes of Health, Toyko, 
Japan). Briefly, cDNA clones pLRB118 (35) and pLR~x6 (36) were 
inserted into EcoRI and HindlII sites respectively of the cassette 
plasmid pmoRH, excised by Sill digestion and ligated with the 
Sfil linearized cosmid vector dCHD2L (34). MHC class II and in- 
variant chain negative rat-2 cells (106) were transfected with 5/ig 
of cosmid DNA employing the DOTAP procedure (Boehringer 
Mannheim, Mannheim, Germany) following the supplier's instruc- 
tions. Transfectants were selected using Hygromycin B at 200/xg/ml 
added 48 h  after transfection. 
Cytokine assays were performed on the culture supernatants of 
the various T  cell lines  as described previously (37)  after 48 h of 
antigen-specific restimulation. IFN-3' levels were measured using 
a  rat  IFN-3' ELISA kit  (Holland  Biotechnologies,  Leiden,  The 
Netherlands). The IL-2-dependent CTLL cell line was used to assay 
IL-2 activity using mouse rlL-2 as a standard. II--6 activity was de- 
termined using the IL-6--dependent 7TD1 hybridoma cell line. TCR- 
oe//3 activity was assayed using TNF-oe//3--sensitive  LM cells and 
a polyclonal TNF-ot-specific goat antimurine antibody (Genzyme 
Corp., Cambridge, MA). The 7TD1 and LM ceils were generously 
provided by Dr. K. Frei (Universit~itespital  Zurich, Switzerland). 
Cytofluorographic Analysis.  The surface phenotype of the T cell 
lines was investigated by indirect immunofluorescence staining. 2 
x  10  s viable cells were washed with PBS containing 0.2% BSA 
and 10 mM NaN3 and incubated with the primary mAb for 1 h 
on ice. The cells were washed to remove the primary antibody and 
stained with fluorescein conjugated goat anti-mouse IgG (Dianova, 
Hamburg, Germany) for 1 h on ice. Cells were then washed and 
immediately analyzed using a FACScan  |  (Becton Dickinson, Heidel- 
berg, Germany). A live gate was obtained by incubating the cells 
in PBS containing  propidium iodide. 
Induction of EAE.  Lewis rats were injected into the tail vein 
with varying numbers of T cell blasts harvested after 72 h of an- 
tigen driven restimulation.  Animals were cared for in accordance 
with German federal  regulations and weighed and examined for 
clinical  signs of EAE on a daily basis. EAE severity was scored as: 
0, no disease; 0.5, partial loss of tail tonus; 1, complete tail atony; 
2, hind limb paraparesis;  3, hind limb paralysis;  4, moribund;  5, 
death. Demyelination was induced 5 d after the injection ofT cells 
by the intravenous injection of 4 mg of the mouse mAb 8-18C5 
specific for the myelin oligodendrocyte glycoprotein (MOG) (38). 
Histology.  Rats  were  perfused  through  the  heart  with  4% 
paraformaldehyde in PBS and tissue postfixed in the same fixative 
for 3 h at 4~  Alternatively, tissues  were removed and immedi- 
ately snap frozen. Multiple sections were stained with hematox- 
ylin-eosin and Luxol fast blue.  Immunocytochemistry was per- 
formed on both paraffin embedded and frozen sections as described 
previously (39). 
The frequency of inflammatory infiltrates  in the cortex, periven- 
tricular white matter, diencephalon, mesencephalon, cerebellum, 
medulla oblongata, and spinal cord was determined by counting 
the number of perivenous inflammatory cuffs in multiple hema- 
toxylin-eosin-stained sections in standardized regions of a total area 
of 375 mmVanimal. The results are expressed as the number of 
inflammatory infiltrates/mm  2.  The total number of T  cells  and 
macrophages was determined in sections immunostained with the 
appropriate antibodies using a 100-point morphometric lattice placed 
in the microscope's ocular (ocular  x  10, objective  x  100).  The 
total area quantitated was 0.6 mm  2 in the spinal cord and 0.2 mm  2 
in the sciatic nerves and spinal roots and the results are presented 
as the number of cells/mm  2 of tissue area. 
Astrocyte Culture  Astrocytes were prepared from newborn lewis 
rat cerebra. The meninges were removed and a single cell suspen- 
sion prepared by trypsinization and seeded into plastic culture flasks 
(4).  The nonadherent  cells were removed after 4 h  and cultured 
in 5% CO2 at 37~  The medium was first replaced after 24 h 
and subsequently every 3-4 d. After 10 d the primary cultures were 
shaken for 3-5 h  to remove microglial cells.  The remaining ad- 
herent astrocytes were removed by trypsinization and transferred 
to flasks at a density of 3  x  104/cm 2. After a further 2-3 wk in 
culture, the cells were again harvested by trypsinization before use 
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Response to antigens 
Line  No.  Ag  D3  $100/3  PPD  Con A 
mean clam 
LS1  28  10,517  12,651  13  10,876 
LS2  100  5,642  10,764  82  11,440 
SP-D3  524  10,583  8,274  36  10,722 
S1-D1  3  4,310  7,710  2  8,869 
$1-E12  410  2,968  5,212  171  9,242 
S 1-F5  5  2,643  7,082  2  10,176 
$1-D2  6  2,457  10,354  3  9,955 
$1-G5  7  2,133  5,533  3  9,663 
$1-F12  5  2,096  7,300  3  11,699 
$1-D12  21  1,160  7,173  7  9,336 
$1-E8  6  1,037  4,111  4  8,749 
$1-E2  6  1,096  8,450  8  10,284 
$1-G12  4  755  4,788  6  10,087 
$1-F4  124  552  4,512  7  11,233 
$1-E3  6  452  2,590  0  9,70i 
$1-F6  28  375  6,746  8  11,288 
$1-F8  4  318  10,205  3  12,203 
$1-C7  3  218  6,049  3  9,219 
$1-G7  8  131  9,079  5  10,614 
$1-G6  3  103  10,574  2  12,408 
$1-G9  1  54  2,588  2  8,281 
$1-G8  6  8  3,232  3  5,817 
Antigen specific T line cells (2  x  104/well) were cultured  in triplicate with irradiated (4,000 rad) syngeneic tbymocytes (0.9  x  106/we11) in the 
presence or absence of either the synthetic rat $1003 peptides (Table 1), bovine $1003, PPD (final concentrations 10 #g/ml), or Con A (2.5/~g/ml) 
for 3 d.  Cultures  were pulsed with [3H]TdR for the last 16 h of the 72-h culture and the incorporation of isotope determined as described. The 
results are presented as the mean cpm obtained, standard deviations were no more than 16%. In addition to the response to peptide D3 the following 
responses to peptides C6 (LS1, 305 cpm;  LS2, 410 cpm;  $1-F4, 264 cpm) and A5 ($1-E2, 324 cpm) were observed. 
Table  3.  Surface Phenotype of LS and $1 SlOOfl-specific T  Cell Lines 
Line  W3/13  W3/25  OX8  OX39  OX22  R73  R78  B73  G101  HIS42 
LS1  99.0  96.9  2.5  98.7  0.3  99.0  4.1  4.4  11.3  15.7 
LS2  98.9  98.1  4.5  95.8  0.4  99.7  1.8  2.5  3.0  7.8 
S1-D1  99.7  99.2  1.2  99.6  0.4  99.9  0.3  0.4  9.8  7.8 
$1-D2  99.4  98.3  1.8  98.8  0.47  100  0.2  0.4  4.8  82.0 
$1-C7  99.3  97.4  1.1  97.3  0.4  99.9  0.4  0.4  0.3  50.0 
$1-G7  98.1  99.3  1.4  100  0.6  99.6  0.4  0.4  0.4  7.8 
$1-G9  99.6  99.3  2.9  99.9  0.5  99.9  0.2  0.5  0.2  98.8 
SP-D3  99.7  96.3  2.2  96.4  0.3  99.9  1.8  8.9  3.5  14.4 
Viable lymphoblasts (2  x  10  s) were incubated with the appropriate mouse mAb and subsequently stained with FITC-conjugated goat anti-mouse 
IgG and analyzed by FACScan  |  Controls  were  stained with the second Ab alone. The results are indicated as the percent of positive cells. 
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Supernatant activities 
Cell line  IFN-3~  IL-2  IL-6  TNF 
mean  +_ SE 
LS1  >10,000  6.8  +  0.3  1358  _+  612  308  _+  82 
$1-D2  >10,000  1.8  _+  0.1  1325  _+  632  158  +  39 
SP-D3  >10,000  2.2  _+  0.2  1813  _+  750  108  _+  23 
CP1  >10,000  2.9  _+  0.4  127  _+  63  193  +_  87 
Z85  >10,000  ND  490  _+  270  705  _+  79 
34LMR  >10,000  0.9  _+  0.1  1313  _+  575  220  _+  77 
APC control  <250  ND  150  ND 
in cytotoxicity and proliferation assays. These cultures contained 
>97% GFAP  + cells of which >80% were S100fl  +. Microglia were 
not detected. 
Astrocyte Cytotoxicity Assays.  Astrocytes  harvested by trypsini- 
sation were cultured in 96-well flat-bottom plates in complete basal 
medium (Eagles) (BME) (104/well) in the presence or absence of 
100 U/ml of rat rlFN-7 (Holland Biotechnologies)  for 48 h before 
use in either cytotoxicity or proliferation assays. 
Cytotoxicity was determined by 51Cr release (40). The cells 
were labeled with 51Cr (1/~Ci/10 4 cells)  for 2 h at 37~  Excess 
51Cr was removed by washing the cells three times, followed by 
incubation at 37~  for 5 h and a second round of  washing. Freshly 
harvested T cell blasts were added to the labeled astrocytes  in com- 
plete DME to give different E/T ratios in the presence or absence 
of the antigen (10/~g/ml). Radioactivity was measured in tripli- 
cate using a gamma counter (Cobra Auto-gamma 5003; Packard) 
after a 12-h incubation. Maximal lysis was determined after incu- 
bation of the astrocytes with 2.5% Triton X-100. 
Results 
Characterization of SIOOfl-specific T Cell Lines.  Lewis rats 
immunized with bovine S100fl mounted a vigorous T  cell 
response to this antigen and of a total of 61 S100fl-specific 
T cell lines generated during this study, 21 were investigated 
in more detail; 2 T cell lines derived from bulk cultures (LS1 
and LS2); and a further 19 S100fl-specific $1 T cell lines de- 
rived from microcultures. After three restimulation cycles the 
T  cell lines were specific for bovine S100fl protein and ex- 
hibited no residual response to PPD  (Table 2). 
The eight S100fl-specific T  cell lines analyzed by FACS  | 
all  exhibited  the  classical  W3/13 +,  OXS-,  CD25 +  and 
TCR-odfl + phenotype of CD4 + rat T  cell lines.  However 
they are clearly differentiated from encephalitogenic CD4 § 
MBP-specific  rat T  cell lines and clones by their TCR Va 
gene usage (Table 3).  Unlike the MBP-specific  T  cell lines, 
S100fl-specific T  cell lines do not preferentially use TCR. 
Va8.2. 
The spectrum of cytokines secreted by representative T cell 
lines specific for either S100fl (LS1, S1-D2,  SP-D3)  or MBP 
(Z85  [37] CP1 [34], 34LMR) was analyzed during the first 
48  h  of an antigen-specific restimulation. All T  cell lines 
secreted IFN-% IL-6, and TNF-o~ into the medium and IL-2 
was detected at low levels in the supernatants with the ex- 
ception of Z85 (Table 4). The production of IFN-3r indicates 
that these cell lines  are of the Thl  subtype. 
The MHC restriction of the Lewis rat T cell response to 
bovine S100fl was established using the T  cell line $1-D2. 
The anti-rat I-A mAb OX6 (125/~g/ml) reduced the prolifer- 
ative response  of this T cell line to S100fl by 70%, whereas 
the same concentration of mAb reduced the proliferative re- 
sponse of a control MBP-specific T cell line, C1-C9, by 97%. 
The mAbs OX17 and OX18 had no significant effect on the 
proliferative response of either T cell line. These results were 
confirmed using the transfected rat-2 mouse L cell line RT3.3, 
which expresses both the c~ and fl chains of Lewis rat I-A. 
This mouse fibroblast call line was capable of acting as an 
APC in vitro inducing an antigen-specific proliferative re- 
sponse  in both T  cell lines tested (Table 5). 
Identification of the Target Epitopes and V•  TCR  Usag~  A 
panel of sixteen overlapping synthetic rat S100fl peptides (Table 
1) was used to identify  T cell epitopes recognized by the S100fl- 
specific T cell lines. The T cell lines LS1 and LS2 both recog- 
nized an immunodominant epitope common to both rat and 
bovine S100fl located within the COOH-terminal sequence 
of the protein, amino acid 76-91, peptide D3 (Fig.  1). Anal- 
ysis of the $1 T  cell lines sdected from serial dilutions of 
the original lymph node cell preparations confirmed that the 
rat S100fl sequence 76-91 was a dominant epitope with re- 
spect to the T cell response to bovine S100fl (Table 2). How- 
ever, although all $1 T  cell lines proliferated strongly in re- 
sponse to native bovine S100fl, the proliferative response to 
this epitope was significantly  lower than that seen in the bulk- 
derived T  cell lines LS1 and LS2.  Proliferation in response 
to peptide D3 ranged from 20 to 55%  of the response to 
bovine S100fl for eight of the $1 T cell lines analyzed, while 
the remaining T  cell lines responded poorly to this rat epi- 
tope. In the case of the T cell hnes such as $1-G8 and $1-G9 
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mAb added 




Thy  +  9534  -+ 380  2832  .+  364  (70.3)  8268  -+  413  7846  +  471 
Thy  -  4  +_  2  ND  ND  ND 
RT3.3  +  1085  _+  430  ND  ND  ND 
RT3.3  -  6  -+  2  ND  ND  ND 
Thy  +  4602  -+  920  134  _+  105  (97.1)  5425  +  109  3272  _+  262 
Thy  -  4  _  2  ND  ND  ND 
RT3.3  +  1136  .+  511  ND  ND  ND 
RT3.3  -  4  _+  4  ND  ND  ND 
The MHC restriction of the T cell lines $1-D2 (S100B-specific) and C1-C9 (MBP-specific) was determined using the mAbs OX6, OX17, and OX18. 
Confirmation that these responses were I-A restricted was obtained using the transfected mouse L cell line, KT3.3, that expresses Lewis rat KT1B 1. 
Expression was confirmed by both FACS  |  analysis and biosyntheic labelling. The data are presented as the mean cpm of triplicate cultures _+ SD. 
The percent inhibition  obtained in the presence of the mAb OX6 is given in brackets. 
there was no response to any of the peptides tested indicating 
that they recognize bovine S100/~-specific epitopes (Table 2). 
The T cell line, SP-D3, established from Lewis rats immunized 
with  the  peptide  D3  (amino  acid  76-91),  as  anticipated, 
proliferated vigorously in response to both the immunizing 
peptide and native bovine $100/~  (Table 2).  All subsequent 
studies were performed using the T  cell lines LS1, LS2, $1- 
D2, $1-C7, $1-G7, $1-G9, and SP-D3, which exhibit differing 
degrees of reactivity with the immunodominant peptide amino 
acid  76-91. 
FACS  |  analysis using a panel of four murine mAbs recog- 
nizing  defined  rat  TCR  V0  products  revealed  that  only 
2-4% of the LS1 and LS2 S100~-specific bulk culture T  cell 
lines expressed V08.2 on their surface (Table 3). The extent 
of Va8.5 expression was also very low, whereas V~10 usage 
was slightly higher (3-11%), as was usage of V016 (8-16%). 
The SP-D3  T  cell line raised against the immunodominant 
peptide D3  also expressed low levels of V~8.2  (2%),  V010 
(4%),  and V~8.5  (9%),  and  again a  significant  proportion 
of Va16 (14%).  None of the $1 T  cell lines tested expressed 
either V~8.2  or V~8.5,  whereas V~16 usage was  •50%  in 
$1-C7, 80% in $1-D2, and 100% in $1-G9. Within the limits 
of the technique used these results demonstrate that unlike 
the  T  cell response to MBP,  the  Lewis rat  T  cell response 
to $100~  does  not  preferentially  use TCR  V~8.2. 
SlOOfl-specific CD4 + T  Cell Lines Induce an Autoimmune 
Panencephalitis  with  Uveoretinitis,  Rather  Than  a  Pure  En- 
cephalomyelitis.  Naive  Lewis  rats  injected  with  5  x  10 6, 
107, or 2  x  107 LS1 and LS2 lymphoblasts failed to exhibit 
any dose-related clinical signs of EAE.  All animals began to 
lose weight 4 d post T  cell transfer and exhibited a transient 
loss of tail tone that lasted a further 3-4 d.  After this time 
the animals began to recover weight (Fig. 2). No other clin- 
ical signs of disease were noted, in particular hind limb parapa- 
resis, paralysis, and urinary incontinence,  which are the clin- 
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Figure  1.  Epitope specificity  of the SlOOB-specific  T cell line, LS1. LS1 
T line cells were restimulated with either native bovine S100fl, or syn- 
thetic rat S100B peptides (see Table 1) as described in the text. Only the 
overlapping COOH-terminal peptides amino acids 71-85 and amino acids 
76-91 induced a significant proliferative response of the LS1 T cell line 
in vitro locating the immunodominant  T cell epitope(s) to this domain 
of the molecule. No other peptides were found to initiate a significant 
proliferative response in either this, or any other of the T cell lines tested. 
ical hallmarks of MBP-induced  EAE,  were absent.  Similar 
losses of weight and tail tone were also observed in animals 
injected  with  107  T  cell  blasts  obtained  from  the  S100fl- 
specific T  cell lines SP-D3, S1-D1, and $1-D2. The adoptive 
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Figure 2.  The clinical course of  disease  induced 
by the  adoptive transfer of CNS-autoantigen- 
specific  T cell lines. Representative  results obtained 
after the adoptive transfer of (a) closed circles, 107 
freshly activated S100~-specific  T ceUs (line LS1); 
open circles, 107 freshly activated PPD-speciiic T 
cells; (b) 10  ~ freshly activated SP-D3 T line cells 
specific  for the synthetic  S100B  peptide D3, amino 
acid residues 76-91; (c)  107  freshly activated 
S100B-specific T cells (line LS1) in combination 
with an intravenous injection of 4 mg of the mAb 
8-18C5 5 d after T cell transfer (arrow). due to the 
severity of the disease induced after the mAb 
transfer animals were perfused on day 8; (d) 107 
freshly activated MBP-specific  T cells (T cell line 
CP1). 
transfer of 107 $1-G7 or $1-G9 T call blasts, which respond 
poorly if at all to the peptide D3 (Table 2) failed to induce 
any clinical changes in naive recipients.  Controls injected with 
the same doses of PPD-specific T  cell blasts showed no loss 
of weight, or tail tone, whereas Lewis rats injected with com- 
parable numbers of MBP-specific T  line cells developed se- 
vere clinical  signs of acute EAE by day 4  (Fig.  2). 
Rats were perfused 6 d after T cell transfer and the CNS 
(brain,  spinal cord, optic nerve), peripheral nervous system 
(PNS) (nerve roots, sciatic nerve, trigeminal nerve), eyes, heart, 
lungs, tongue, thymus, kidney, spleen, bowel, adrenal glands, 
and salivary glands removed for histopathology. 
Surprisingly, despite the absence of obvious signs of CNS 
disease this analysis revealed that, with one exception (T cell 
line $1-G9), all the S100B-specific  T  cell lines induced a se- 
vere inflammatory response in the CNS (Fig.  3, a, c, d, and 
J). Inflammatory infiltrates were also seen in the peripheral 
nerve roots in 60% of animals,  but only very rarely in the 
sciatic  nerve. In contrast, uveitis was very common,  occur- 
ring in 49 of the 60 animals examined and was in some cases 
associated with scleritis, iridocyclitis,  and periphlebitis retinae 
(Fig.  3, g, h, and i). Uveitis was not observed in any animal 
with MBP-induced EAE. No inflammatory responses were 
seen in any other  of the tissues examined. 
The intensity of the inflammatory response induced in the 
CNS by the S100~-spedfic T cell lines was qualitatively similar 
to that seen in animals with severe (grade 2+), EAE induced 
by a MBP-specific T cell line (Figure 3, a and b). However, 
unlike MBP-induced disease,  in which the inflammatory le- 
sions are most prominent in the spinal cord and rare in brain, 
S100~-specific T cell lines induced an inflammatory response 
throughout  the CNS, in which involvement of both brain 
and spinal cord was common (Fig.  3; Table 6). The differ- 
ence between the two models was most marked in the cortex 
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and mesencephalon, both of which are strongly involved in 
the S1003-specific T  cell-mediated  disease (Table  6).  This 
S1003-specific T  cell-mediated inflammatory disease of the 
CNS thus qualifies as an experimental autoimmune panen- 
cephalitis  (EAP). 
The Clinical Course and Histopathology of SlOOp-specific T 
Cell-mediated  CNS  Inflammation  Can  Be Modulated  by the 
Cotransfer of MOG-specific  Antibody.  In view of the exten- 
sive inflammation  seen in animals  receiving S100/5-specific 
T cell lines it was of interest to determine whether these clin- 
ically silent lesions could be modulated by cotransfer of the 
mAb 8-18C5. This mAb recognizes an epitope of the MOG 
exposed on the surface of the myelin membrane. Intravenous 
injection of this antibody in animals with MBP-mediated EAE 
enhances the clinical severity of the disease and induces local 
demyelination  (41,  42). 
In  the present  study,  intravenous  injection  of 4  mg  of 
purified 8-18C5 5 d after the transfer of S100/3-specific T cells 
rapidly induced the classical signs of EAE, paraparesis/paral- 
ysis within 24 h (Fig.  2). This was associated with the for- 
mation of large plaques of demyelination throughout the CNS 
(Fig. 3 e). Injection of the same dose of a control mouse IgG 
preparation failed to induce any enhancement in either din- 
ical status or demyelination in animals with S100B-induced 
CNS inflammation. The intense inflammatory response seen 
in the CNS of animals  injected with S100~-specific T  cell 
lines is therefore associated with an enhanced permeability 
of the BBB sufficient to permit  the 8-18C5 mAb to enter 
the CNS and initiate demyelination. 
The Failure of SlOOp-specific T Cells to Induce Severe Clinical 
Disease Is Associated with a Decreased Activation of ED1 + Mac- 
rophages in the CNS.  To investigate the cellular/physiolog- 
ical basis responsible for the inability of S100B-specific T cell 
lines to induce severe neurological disease, we examined the 824  Experimental Autoimmune Panencephalitis and Uveoretinitis Table  6.  Topographic Distribution of the Inflammatory 
Infiltrates in MBP- and SlOOfl-specific T  Cell-mediated  Disease 
T  cell  line specificity 
Tissue  MBP  Sl00~/ 
Cortex*  0.004  _+  0.002  0.746  +  0.088 
White  matter*  0.107  _+  0.053  0.310  +_  0.050 
Diencephalon*  0.209  _+  0.055  0.965  _+  0.200 
Mesencephalon*  0.499  _+  0.109  1.500  +  0.064 
Cerebellum  0.571  +  0.187  0.235  +  0.043 
Medulla  1.711  _+  0.380  1.355  +  0.228 
Spinal  Cord  2.040  2.990 
Lewis rats were injected intravenously with activated MBP-specific (CP1; 
n  =  7), or S100/3-specific (LS1; n  =  6) T  line cells and perfused 6 d 
later  as  described  in  the  text.  The  number  of  inflammatory 
infihrates/mm 2 determined in multiple tissue sections. The distribution 
of the lesions is strikingly different in the two models, particularly with 
respect to the cortex, white matter, diencephalon, and mesenencephalon 
that are intensively involved in the $1003 paradigm, but only exhibit 
moderate inflammation following the transfer of MBP-specific T cells (* 
significance at 98%  in analysis of variance). 
composition  and  distribution  of the  infiltrating  inflamma- 
tory cells in  the  CNS.  This  data was compared with  that 
obtained from studies on MBP-specific T  cell-mediated EAE. 
Even after hematotoxylin-eosin  staining it was apparent 
that in the S100~-specific T  cell induced disease model, the 
perivascular lesions were very large as compared with those 
seen in MBP-specific T  cell-induced  EAE.  Large numbers 
of cells were tightly packed into clearly delineated perivas- 
cular  cuffs  of inflammatory  cells.  Quantitative  immuno- 
histochemical analysis revealed that the absolute number of 
W3/13 + T  cells present in the CNS on day 6  was at least 
10  x  greater in both the perivascular and parenchymal com- 
partments of animals infected with the S100/3-specific T  cell 
lines,  than  in  MBP-induced  EAE  (Table 7). 
However, in contrast to the numbers of T cells found within 
the CNS,  the expression of ED1  as a marker for lysosomal 
activation  in  macrophages  was  lower  in  rats  with  S100B- 
induced CNS inflammation.  ED1 § cells are the major com- 
ponent of the classical EAE lesion (Table 7), where they ac- 
count for up to 80%  of the infiltrating inflammatory cells, 
both in the perivascular space and parenchyma.  This is not 
the case in S100B-specific T  cell mediated  CNS  inflamma- 
tion.  Although  the absolute number of ED1 § cells present 
in the CNS is approximately equal in both MBP- and S100~- 
specific paradigms, the proportion of this cell type entering 
the parenchyma is low (Table 7). Moreover, the intensity of 
staining with the ED1  mAb appeared weaker in the $100~ 
paradigm, suggesting that these cells are poorly activated in 
this model. To ensure that this observation was not a staining 
artifact, macrophage infiltration was also evaluated using ad- 
ditional  markers  for rat  macrophage populations  on  fresh 
frozen  sections.  The  macrophage-specific  mAbs  ED3  and 
TRPM3 also demonstrated that in S100/~-mediated EAP, the 
number of activated macrophages present in the perivascular 
cuffs and  parenchymal infiltrates  was lower  than  that  seen 
in MBP-mediated EAE.  In contrast,  the mAb ED2,  which 
stains a population of resident perivascular cells in the CNS, 
was found to identify a similar number of cells in both MBP- 
and S100~/-mediated diseases. Similarly, no difference in the 
phenotype of ramified microglia in the parenchyma was found 
between  the  two  experimental  models. 
Astrocyte  Interactions  with  SIOOff-specific  T  Cell Lines  In 
Vitra  The cytotoxicity of several pathogenic CD4 + S100/3- 
specific T  cell lines was assessed in vitro using syngeneic as- 
trocytes as targets in  a chromium  release assay.  The lewis 
rat MBP-specific T  cell line Z85 (40) and PPD-specific T  cell 
line LP-PPD1  (37) were used as positive and negative con- 
trols  for T  cell  mediated  cytotoxicity.  In  agreement  with 
previous  studies  the  Z85  T  cell line effectively lysed IFN- 
induced, Ia + astrocytes in the presence of its specific antigen, 
MBP (40). In striking contrast, the S1008-specific T cell lines 
LS1,  S1-D2 and SP-D3,  which induce an inflammatory re- 
sponse in the CNS in vivo, are completely unable to lyse Ia § 
astrocytes in vitro in the presence of S100B (Table 8). Thus, 
unlike  classic  encephalitogenic  MBP-specific  T  cells  (40), 
pathogenic  CD4 +  S100~-specific T  cell lines  are not  cyto- 
toxic. Moreover, although the astrocytes used in these studies 
Figure  3.  Inflammatory lesions in the rat brain after the adoptive transfer of S1003- or MBP-specific  T cell lines. (a) Perivascular  inflammatory infiltrates 
are present in the meninges and spinal cord tissue (arrows) 6 d after the adoptive transfer of 107 S1003-specific T line cells. S100/~-specific  immunocyto- 
chemistry (brown) reveals that $100~ is confined to astrocytes in the white and grey matter, lmmunocytochemistry for $100~, nuclear staining with 
hematoxylin;  x70. (b) Inflammatory infiltrates in the spinal cord (arrows) 6 d after the adoptive transfer of 5  x  106 MBP-specific T line cells. MBP- 
specific immunocytochemistry (brown)  reveals  that MBP is present in the myelin sheaths of both the white and grey matter. Note however the distribution 
of MBP between white and grey matter is the reverse of that seen for $1003 in a. Immunocytochemistry for MBP, nuclear staining with hematoxylin; 
x 70. (c) After the adoptive transfer of S100B-specific T cells the majority of the cells in the inflammatory infiltrates are T cells. Immunocytochemistry 
with W3/13;  x360.  (d) Adjacent serial section to that in c stained with ED1 to identify macrophages in the lesion, note only very few ED1 + cells 
are present in the infiltrate; x360. (e) Co-transfer of S1003-specific T cells followed 5 d later by an intravenous injection of monoclonal MOG-specific 
antibody. Injection of the antibody induces the formation of extensive confluent plaques of demyelination in the spinal cord white matter. Klfiver 
myelin stain;  x70. (D Inflammatory infiltrate in the frontal cortex induced by the adoptive transfer of S1003-specific T cells. $100~ immunoreactivity 
(brown) is confined to astrocytes. Immunocytochemistry for $1003, nuclear staining with hematoxylin; x 250. (g) The adoptive transfer of S100B-specific 
T cells induces a pefivenous inflammatory infiltrate in the retina (periphlebitis retinae); hematoxylin-eosin;  x 175. (h) Extensive inflammation in the 
uvea and sclera of the eye induced by the adoptive transfer of S1003-specific T cells. Immunocytochemistry for $1003 reveals the presence of $100/~ 
in many cells throughout  the tissue. Immunocytochemistry for $1003, nuclear staining with hematoxylin;  x250.  (i) Extensive inflammation in the 
iris induced by the adoptive transfer of S100~-specific T cells, iris stroma cells are immunoreactive for S100~. Immunocytochemistry for S100~, nuclear 
staining with hematoxylin;  x 250. 
825  Kojima et al. Table 7.  Quantitation  of Macrophage and T  Cell Infiltration into the CNS 
Perivascular 
T  cell 
specificity  ED1  W3/13  Ratio*  ED1 
Parenchym 
W3/13  Ratio 
MBP  289  (31)  38 (41)  7.6  803  (52) 





w3/13 + and ED1 + cells were quantitated in multiple spinal cord sections as described in the text. 
were $100~ § we were unable to demonstrate the presenta- 
tion of autologous $100~/by astrocytes to syngeneic T  cell 
lines in either proliferation or cytotoxicity assays. 
Discussion 
This study demonstrates that in the Lewis rat,  autoim- 
mune T  cells  specific for an astrocyte-derived autoantigen, 
S100B, adoptively transfer an unusual type of inflammatory 
CNS disease,  which can be best described as EAP. Clinical 
disease and histopathology in this new model of tissue specific 
autoimmunity differ dramatically from that seen in "classical" 
MBP-induced EAE, and in some respects may resemble more 
closely the human disease  MS. 
In their basic characteristics, autoaggressive $100~/- and 
MBP-specific T cell lines are indistinguishable; both express 
the CD4+CD8 -  membrane phenotype and use the TCR- 
ol/~;  their  antigen  specific  responses  are  MHC  class  II 
(RT1.B  1)  restricted,  and,  in  addition,  both  MBP-  and 
S100B-specific T cell lines are Thl-like, synthesizing IL-2 and 
IFN-3' upon activation. For practical reasons, the S100B-specific 
T cell lines were selected for reactivity against bovine $100~ 
protein. Epitope mapping using synthetic peptides representing 
rat $100~ sequences proved that most of these T  cell lines 
are truly self-reactive.  This was most dearly seen in the T 
cell lines LS1 and LS2 derived from the bulk lymph node 
cell cultures, in which the proliferative response to the COOH- 
terminal rat $100~ peptide, amino acids 76-91, was virtually 
equivalent to that obtained with the native bovine protein. 
This epitope appears  to be immunodominant in the bulk- 
derived S100B-specific T cell lines and its pathogenicity was 
confirmed using a T cell line generated using a synthetic rat 
$100~76-91 peptide. In contrast to the MBP-specific T cell re- 
sponse, recognition of this immunodominant $1003 epitope 
was not however found to be associated with preferential usage 
of the TCR V~8.2 gene. 
Adoptive transfer experiments established that this S100~- 
specific T  cell response is highly pathogenic. However the 
disease induced by S100~-speeific T cell lines differs radically 
from that produced by MBP-specific T cells. Despite the in- 
tense inflammatory response in the CNS, clinical signs of neu- 
rological dysfunction were minimal.  Moreover, the histo- 
Table 8.  Cytotoxicity  of S100fl- or 193 Peptide-specific T  Cell Lines 
Effector/target (E/T) ratio 
Line  A  10:1  3:1  1:1  0.3:1  0:1 
LS1  +  0  0  0  0  0 
-  0  0  0  0  0 
$1-D2  +  0  0  0  0  0 
-  0  0  0  0  0 
LS-D3  +  0  0  0  0  0 
-  0  0  0  0  0 
Z85"  +  31.7  +  3.5  17.6  +  1.6  8.7  +  2.5  0  0 
-  0  0  0  0  0 
LP-PPD1  +  0  0  0  0  0 
-  0  0  0  0  0 
Astrocytes were seeded as target cells in 96-well fiat-bottom plates at a density of 104 cells/well. After a 48-h incubation with IFN- (100 U/ml) 
to induce Ia expression, the cells were labeled with SlCr (1 #Ci/10 4 cells),  and freshly activated T lymphoblasts added in different E/T ratios in 
the presence  or absence  of the appropriate  antigen ([bovine  $1003, guinea  pig MBP, PPD] at 10 #g/ml). Lysis  was determined  using triplicate  samples 
after a 12-h incubation. The results are given as the mean specific lysis _+ SD. 
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the MBP-mediated model with respect to the cellular com- 
position and tissue distribution of the inflammatory infiltrates. 
The inflammatory infiltrates in the CNS of rats injected 
with S100/3-specific T  ceils were composed predominantly 
of T cells and contained approximately 10 times the number 
of infiltrating T cells seen in rats injected with an equivalent 
number of encephalitogenic MBP-specific T cells. In contrast, 
activated macrophages that are the dominant cell population 
in MBP-induced EAE lesions (43,  44),  accounted for only 
a minority of the infiltrating inflammatory cells in the S1003 
paradigm. 
The distribution of lesions in S100~-induced disease cor- 
related roughly with the pattern of S1003 expression within 
the CNS and adjacent tissues.  S1003 is present in astrocytes 
(in both the grey and white matter) in the CNS, in Schwann 
ceils in the PNS and in astrocytes and Miiller ceils in the eye 
(45).  Thus inflammatory infiltrates were noted throughout 
the CNS, including cortex, telencephalon, optic nerve, and 
cerebellum, as well as in the PNS and eye. This is in contrast 
to MBP-induced EAE in which the target autoantigen is only 
expressed by myelinating oligodendrocytes and Schwann cells 
and is not expressed in the uvea or retina as these tissues are 
not myelinated. Uveitis is therefore not seen in the MBP- 
induced model of EAE. MBP and S100/3 are, however, both 
expressed at high concentrations along the whole length of 
the spinal cord, as well as in the brain. It is therefore striking 
that whereas in MBP-induced EAE the lesions tend to be 
concentrated in the caudal segments of the spinal cord (46), 
in S100/~-induced  disease lesions are found throughout the 
CNS. The adoptive transfer of S100/~-specific  T line cells there- 
fore induce an EAP that is clearly distinguishable from the 
classical model of MBP-induced encephalomyelitis. This ob- 
servation indicates that as yet unspecified factors modulate 
the ability of local APCs within the brain to process and 
present specific autoantigens within different regions of the 
CNS. 
The ability of S100~3-specific T cells to induce an intense 
inflammatory response throughout the CNS is in marked con- 
trast to their inability to induce severe neurological dysfunc- 
tion.  Considering the number and the localization of the 
inflammatory infiltrates,  one would expect the animals to de- 
velop severe, if not lethal disease. There are at least two ob- 
servations that could account for this discrepancy, and these 
are by no means mutually exclusive. 
First, it should be remembered that most, if not all, en- 
cephalitogenic MBP-specific T cells exhibit antigen specific, 
class II MHC-restricted cytotoxicity in several different spe- 
cies (40,  47,  48). It was postulated that target cell lysis, as 
measured in vitro, reflected the encephalitogenic potential of 
MBP-specific T cells in vivo. However, in contrast to MBP- 
specific T cells, none of the S100B-specific T cell lines tested 
were cytotoxic. 
Second, it is well established that macrophages are criti- 
cally involved in mediating clinical disease in MBP-mediated 
EAE. Depletion of the macrophage population has been shown 
to migrate clinical EAE (49, 50) despite the continued pres- 
ence of inflammatory infiltrates in the CNS (50).  Interest- 
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ingly,  in  EAP  there  is  a  reduced migration  of activated 
(ED1 +) macrophages from the perivascular space into the 
CNS parenchyma. This could account in part for the mild 
clinical course of EAP and can be best explained by a deficit 
in the production of cytokines known to recruit individual 
mononuclear blood cells into areas of inflammation. Although 
cytokine assays for IL-2, TNF-oe/I3 and IFN-3, did not reveal 
gross differences between MBP and S10013-spedfic  T cells (both 
behaved like Thl cells), there could be dissimilarities in the 
release of other chemotactic cytokines such as IL-8, MIP-1, 
CP-1, MCP-1, etc., in vivo. These factors are under investi- 
gation at present, although at present we cannot yet estab- 
lish any direct link between the absence of S100B-specific T 
cell-mediated cytotoxicity and the composition of the inflam- 
matory infiltrates. 
This new model of autoimmune-mediated CNS inflam- 
mation has direct relevance for our understanding of the im- 
munopathogenesis of MS and other putative autoimmune 
inflammatory diseases of the nervous system. Although the 
human retina and uvea are not myelinated (51), these tissues 
are involved in some patients with MS (51, 52, reviewed in 
26),  periphlebitis retinae occurring in  10-40%  of patients 
(51, 26) and in another series of cases inflammation of the 
urea was seen in 5-27%  of the patients  studied (53-55). 
Moreover,  pathological  abnormalities  in  the  retinal  en- 
dothelium of patients with acute isolated optic neuritis are 
also a significant additional risk factor for MS (56). The ab- 
sence of myelin in these tissues is difficult to reconcile with 
the concept that MS is exclusively caused by a myelin-specific 
autoimmune response, particularly as inflammation of these 
tissues was not seen in MBP-specific T cell-mediated EAE. 
Our results raise the possibility the primary autoantigen in 
some cases of MS may not be solely derived from myelin, 
but that other cellular compartments in the CNS may also 
provide appropriate autoantigenic targets. This notion that 
a nonmyelin autoantigen could have a role in a demyelinating 
inflammatory disease may at first seem bizarre. However, nu- 
clear magnetic imaging studies in MS and EAE also indicate 
that the primary event in disease pathogenesis is an increased 
permeability of the BBB (57,  58) and that this is triggered 
by a T cell-mediated response in the CNS (59). We have now 
demonstrated that this inflammatory response need not neces- 
sarily be myelin specific, although an additional myelin-specific 
effector mechanism, such as MOG-specific autoantibody re- 
sponse is required to produce a demyelinating white matter 
pathology similar to that seen in MS.  The immunopatho- 
genesis of the MS lesion, at least in some cases could be a 
consequence of multiple autoimmune responses to a variety 
of CNS autoantigens. 
Finally we predict that many additional myelin and non- 
myelin brain determinants will be identified as potential en- 
cephalitogens. This concept is crucial for the future develop- 
ment  of novel  therapeutic  strategies  for  MS,  since  once 
established disease may be driven by a polyclonal T cell-medi- 
ated autoimmune response against different CNS antigens. 
Such responses may also play an important role in the patho- 
genesis of other inflammatory brain diseases, including the 
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